NDC 73043-093-01 - Isosulfan Blue
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73043-093
- Requested NDC
- 73043-093-01
- Package NDCs from labels
- 73043-093-01, 73043-093-06
- Manufacturer
- Devatis, Inc. | SABA Ilac Sanayii ve Ticaret A.S. | DEVA Holding A.S.
- Effective date
- 2026-07-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Isosulfan Blue | Devatis, Inc. | SABA Ilac Sanayii ve Ticaret A.S. | DEVA Holding A.S. | 2026-07-01 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Isosulfan Blue | ISOSULFAN BLUE | Mylan Institutional LLC | 1878964e-5220-48c8-a872-dcadbc451aff | 2025-12-15 | Warnings, Adverse reactions | 39N9K8S2A4 |
| Helleborus comp. A | HELLEBORUS COMP. A | Uriel Pharmacy Inc. | 150e57ad-3ed7-5cc9-e063-6394a90a25fe | 2025-11-21 | Warnings | 4J9FJ0HL51 |
| Ionosol MB and Dextrose | DEXTROSE MONOHYDRATE, SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | ICU Medical Inc. | 1b457b1d-0e80-4578-ba6f-dedf513fc962 | 2025-10-30 | Warnings, Adverse reactions | 4J9FJ0HL51 593YOG76RN |
| Me NaPhos MB Hyo 1 | URINARY ANTISEPTIC ANTISPASMODIC | Method Pharmaceuticals | 2ae628e7-3b33-6a9a-e054-00144ff8d46c | 2025-10-21 | Warnings, Adverse reactions | 593YOG76RN |
| Potassium Phosphates | POTASSIUM PHOSPHATES | Hospira, Inc. | 2fcbc814-c7a4-469a-8b1d-6819b961bfb9 | 2025-09-30 | Warnings, Adverse reactions | 4J9FJ0HL51 |
| POTASSIUM PHOSPHATES | POTASSIUM PHOSPHATES IN SODIUM CHLORIDE | Amneal Pharmaceuticals LLC | dce22c93-aa48-48a9-ac8b-716400d33c9e | 2025-09-01 | Warnings, Adverse reactions | 4J9FJ0HL51 |
| Sodium Phosphates | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE AND SODIUM PHOSPHATE, DIBASIC ANHYDROUS | Civica, Inc. | 8fd901e6-30cb-411a-b820-b9e79625ec7c | 2025-08-08 | Warnings, Adverse reactions | 593YOG76RN |
| InterSol | PLATELET ADDITIVE 3 | Fenwal, Inc. | 17dec820-1b57-4ac9-82a8-419cab664a2f | 2025-06-27 | Warnings, Adverse reactions | 593YOG76RN |
| Potassium Phosphates | POTASSIUM PHOSPHATES | Fresenius Kabi USA, LLC | 357c3020-ea6f-4401-a2e7-cebb82b03144 | 2025-04-15 | Warnings, Adverse reactions | 4J9FJ0HL51 |
| Potassium Phosphates | POTASSIUM PHOSPHATES | Cipla USA Inc. | f1f26a17-d2e2-48f5-9054-8ee7e380556e | 2025-02-28 | Warnings, Adverse reactions | 4J9FJ0HL51 |
| Potassium Phosphates | POTASSIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE, DIBASIC | Fresenius Kabi USA, LLC | 475f5cd7-45bd-412a-b419-9962585d6cda | 2025-02-28 | Warnings, Adverse reactions | 4J9FJ0HL51 |
| MB CAPS | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | Allegis Pharmaceuticals, LLC | 2efeb281-b84b-4750-e063-6394a90a27ee | 2025-02-25 | Warnings, Adverse reactions | 593YOG76RN |
| URIMAR-T CAPS | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | Allegis Pharmaceuticals, LLC | cf7c3d65-11d2-49cd-b207-8ccc6a221fe0 | 2025-01-08 | Warnings, Adverse reactions | 593YOG76RN |
| POTASSIUM PHOSPHATES | POTASSIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE, DIBASIC INJECTION, | Amneal Pharmaceuticals Private Limited | 89136c51-a60b-4269-bd05-9489f060a734 | 2024-12-31 | Warnings, Adverse reactions | 4J9FJ0HL51 |
| teruflex blood bag system with diversion blood sampling arm 70 ml cpda-1 | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, AND ADENINE | Terumo Corporation | 86b3a329-c83f-4977-92f5-0e9dfe1872d7 | 2024-10-10 | Warnings | 593YOG76RN |
| TERUFLEX BLOOD with Diversion Blood Sampling Arm 70 mL CPDA-1 | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, AND ADENINE | Terumo Corporation | 39f2e11c-5a31-469f-b725-d096c1674421 | 2024-10-03 | Warnings | 593YOG76RN |
| TERUFLEX Blood Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) for Collection of 450mL of Blood | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, AND ADENINE | Terumo Corporation | 02015040-9b71-4dbe-8f8d-e0d0951e8f93 | 2024-09-19 | Warnings | 593YOG76RN |
| Potassium Phosphate | POTASSIUM PHOSPHATE | Somerset Therapeutics, LLC | 52f07402-1869-4a97-9c92-9729dc611f85 | 2024-07-11 | Warnings, Adverse reactions | 4J9FJ0HL51 |
| Sodium Phosphates | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE AND SODIUM PHOSPHATE, DIBASIC ANHYDROUS | American Regent, Inc. | dc0462ee-4486-418c-865f-e2a71bdb8e9e | 2024-06-06 | Warnings, Adverse reactions | 593YOG76RN |
| Isosulfan Blue | ISOSULFAN BLUE | Eugia US LLC | 61b48ff8-7ace-4ab7-9f58-f250e2830d16 | 2024-02-15 | Warnings, Adverse reactions | 39N9K8S2A4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.